Current Situation Data

HCV & its complications are a real burden to healthcare systems. They impact patient's health, social & economic aspects as well. Following are more detailed estimations about HCV burden in Saudi Arabia

[80,000]

Undiagnosed Saudi individuals with active HCV^1,2

[2.5%]

Estimated new infections
per year^1,2

[~87%]

of Saudis living with HCV may be unaware of their infection status.¹

[18 Billion]

Estimated Saudi Riyals health costs of HCV in KSA until 2030

Individual Burden

74% of HCV patients

develop extrahepatic manifestation during their illness.^4,5

HCV infection can also have an

impact on a patient’s quality of life.⁶

For Every 100 People Infected with HCV⁷

75-80

Will develop Chronic Infection

60-70

Will develop Chronic Liver Disease

5-20

Will develop Cirrhosis

1-5

Will die of cirrhosis or liver cancer

What we aim to achieve by 2030?

Explore All Data

References:

1. Aljumah AA, Abaalkhail F, et al. Epidemiology, disease burden, and treatment strategies of chronic hepatitis C virus infections in Saudi Arabia in the new treatment paradigm shift. Saudi J Gastroenterol 2016;22:269‑81 2. Altraif I. Can hepatitis C virus be eliminated by 2030? Saudi Arabia as an example. Saudi Medical Journal. 2018;39(8):842-845. 3. Global Hepatitis Report 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. 4. Douglass CH, et al. BMC Med. 2018;16:175. doi:10.1186/ s12916-018-1162-z 5. Reau N, et al. Hepatol Commun. 2017;1:439–452. doi:10.1002/hep4.1049 6. Vietri J, et al. BMC Gastroenterol. 2013;13:16. doi:10.1186/1471-230X-13-16 7. Ghany MG, Strader DB, ThoHowlader N, et al. SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.mas DL, et al. Hepatology. 2009;49(4):1335–1374. EMCDDA Insights. Hepatitis C among drug users in Europe. 2016;

Approval Code: ABBV-SA-00012-MC